Plain-English translation of NCT05934669 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing three different medications that are sprayed into the nose to help young children feel calmer and less anxious during minor wound repair procedures in the emergency department. Researchers want to compare Midazolam, Dexmedetomidine, and Ketamine to see which one works best, is safest, and gets children home fastest.
Young children often feel scared and experience pain during emergency procedures, which makes it harder for doctors to help them and stressful for families. Researchers want to find the best medication option that keeps children calm, safe, and comfortable while also speeding up their recovery and discharge from the hospital.
You likely qualify if…
You likely don't qualify if…
If your child is enrolled, one of the three medications will be sprayed gently into their nose about 5–10 minutes before the doctor repairs the cut. You and your child will wait in the emergency department while the medication takes effect, and then the doctor will clean and stitch the wound. Researchers will measure how long it takes for your child to be ready to go home and track how well the medication worked to keep your child calm and comfortable.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
United States